Cap polyposis (CP) is a rare colorectal disease characterized by multiple inflammatory polyps that predominantly affect the rectosigmoid area and that manifests primarily as rectal bleeding with abnor...
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for cap polyposis is limited primarily due to its extreme rarity, affecting fewer than 1 in 1,000,000 people. This rarity restricts the scope of systematic clinical studies and comprehensive research, making it challenging to gather extensive data on the condition. As a result, many aspects of cap polyposis remain poorly understood.
The clinical features of cap polyposis include colorectal polyposis (100% prevalence), constipation (80-99%), abdominal pain (80-99%), hematochezia (80-99%), atrophic gastritis (80-99%), weight loss (30-79%), diarrhea (30-79%), and abdominal distention (30-79%). These symptoms can significantly impact the quality of life and require careful management.
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Currently, there are no orphan drug designations for cap polyposis, but there is one active clinical trial. This trial may provide insights into potential treatments and management strategies for individuals affected by the condition. For more information, you can explore the active clinical trial at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=cap%20polyposis.
Actionable guidance for navigating care for cap polyposis
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for cap polyposis is limited primarily due to its extreme rarity, affecting fewer than 1 in 1,000,000 people. This rarity restricts the scope of systematic clinical studies and comprehensive research, making it challenging to gather extensive data on the condition. As a result, many aspects of cap polyposis remain poorly understood.
The clinical features of cap polyposis include colorectal polyposis (100% prevalence), constipation (80-99%), abdominal pain (80-99%), hematochezia (80-99%), atrophic gastritis (80-99%), weight loss (30-79%), diarrhea (30-79%), and abdominal distention (30-79%). These symptoms can significantly impact the quality of life and require careful management.
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Currently, there are no orphan drug designations for cap polyposis, but there is one active clinical trial. This trial may provide insights into potential treatments and management strategies for individuals affected by the condition. For more information, you can explore the active clinical trial at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=cap%20polyposis.
Actionable guidance for navigating care for cap polyposis
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for cap polyposis is limited primarily due to its extreme rarity, affecting fewer than 1 in 1,000,000 people. This rarity restricts the scope of systematic clinical studies and comprehensive research, making it challenging to gather extensive data on the condition. As a result, many aspects of cap polyposis remain poorly understood.
The clinical features of cap polyposis include colorectal polyposis (100% prevalence), constipation (80-99%), abdominal pain (80-99%), hematochezia (80-99%), atrophic gastritis (80-99%), weight loss (30-79%), diarrhea (30-79%), and abdominal distention (30-79%). These symptoms can significantly impact the quality of life and require careful management.
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Currently, there are no orphan drug designations for cap polyposis, but there is one active clinical trial. This trial may provide insights into potential treatments and management strategies for individuals affected by the condition. For more information, you can explore the active clinical trial at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=cap%20polyposis.
Actionable guidance for navigating care for cap polyposis
To manage cap polyposis effectively, it is crucial to consult a gastroenterologist with experience in inflammatory bowel diseases or colorectal disorders. While there are currently no patient organizations specifically focused on cap polyposis, resources such as GARD (rarediseases.info.nih.gov) may provide valuable information. Additionally, consider participating in clinical trials to contribute to research and gain access to potential new treatments.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.